Oct 15, 2026 07:31AM
Oct 15, 2026 07:30AM
Aug 13, 2026 12:27PM
Aug 13, 2026 07:30AM
May 14, 2026 07:30AM
Apr 7, 2026 08:30AM
Mar 5, 2026 07:30AM CorMedix reports Q4 2025 net revenue of $128.6 million
Mar 5, 2026 07:30AM
Mar 2, 2026 08:30AM
Feb 12, 2026 08:30AM
Feb 2, 2026 08:30AM
Feb 2, 2026 08:30AM
Jan 29, 2026 08:30AM
Jan 9, 2026 08:30AM CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Jan 8, 2026 08:08AM
Jan 8, 2026 08:05AM
Jan 8, 2026 08:02AM
Jan 8, 2026 08:00AM
Dec 18, 2025 08:00AM
Nov 12, 2025 04:05PM
Nov 12, 2025 11:00AM Strong Earnings and Biotech Resilience Define the Midweek Momentum
Nov 12, 2025 07:30AM
Oct 31, 2025 08:30AM
Oct 23, 2025 08:30AM
Oct 21, 2025 08:30AM
Oct 21, 2025 08:30AM
Oct 20, 2025 07:32AM
Oct 20, 2025 07:30AM CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance
Sep 29, 2025 08:30AM
Sep 29, 2025 08:30AM
Sep 9, 2025 04:03AM
Sep 8, 2025 08:30AM
Sep 8, 2025 08:30AM
Sep 8, 2025 08:30AM
Sep 2, 2025 07:30AM CorMedix completes Melinta acquisition, raises 2025 revenue guidance
Sep 2, 2025 07:30AM
Aug 7, 2025 07:12AM
Aug 7, 2025 07:10AM
Aug 7, 2025 07:00AM
Aug 7, 2025 07:00AM
Aug 7, 2025 07:00AM
Dec 4, 2023 08:30AM CorMedix Inc. Announces Partnership With The Leapfrog Group
Jun 28, 2023 05:47PM
Nov 7, 2022 08:32AM
Nov 7, 2022 08:30AM
Aug 9, 2022 08:50AM
Mar 17, 2022 08:30AM
Mar 17, 2022 08:30AM
Nov 2, 2021 09:00PM Bragar Eagel & Squire is Investigating Certain Officers and Directors of Live Ventures, CorMedix, Emergent BioSolutions, and Generac on Behalf of Long-Term Stockholders and Encourages Investors to Con
Mar 1, 2021 09:32AM

1,201,759 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All